Evolutive Potential of Embryos Obtained From Oocytes After Luteal Phase Ovarian Stimulation

Fundacion Dexeus15 enrolled

Overview

The purpose of this study is to evaluate the clinical pregnancy rate per embryo transfer in oocytes recipients obtained after ovarian stimulation during the luteal phase of oocytes donors . This study will be performed in egg recipients and donors but this type of treatment is meant to be implemented in fertility preservation patients

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

INFERTILITY Fertility Preservation Ovulation Induction Vitrification Oocyte Donation

Interventions

gonadotropins plus GnRH antagonistsDRUG

ganirelixDRUG

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 35 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * premenopausal women, 18-35 years old, FSH levels \< 10 mIU/ml; AFC\> 10 * regular cycles * BMI \< 28 * signed informed consent Recipients: * Infertile women eligible for oocytes donation * BMI \< 35 * Signed informed consent form Exclusion Criteria: -Polycystic ovarian syndrome, gonadotropins allergy Recipients: * Women eligible for oocytes donation * BMI \>35 * Uncontrolled Endocrine Pathology

Locations (1)

Departamento de Obstetricia Ginecologia y Reproducción. Institut Universitari Dexeus

Barcelona, Barcelona, Spain

Outcomes

Primary Outcomes

Pregnancy rate

Time frame: six weeks after transfer procedure

Secondary Outcomes

Number of Mature oocytes

Time frame: Day of oocyte retrieval

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.